ATE72756T1 - Verfahren zur herstellung eines biologischen stoffes. - Google Patents
Verfahren zur herstellung eines biologischen stoffes.Info
- Publication number
- ATE72756T1 ATE72756T1 AT85104272T AT85104272T ATE72756T1 AT E72756 T1 ATE72756 T1 AT E72756T1 AT 85104272 T AT85104272 T AT 85104272T AT 85104272 T AT85104272 T AT 85104272T AT E72756 T1 ATE72756 T1 AT E72756T1
- Authority
- AT
- Austria
- Prior art keywords
- biologic
- production
- serum
- triglycerides
- virus
- Prior art date
Links
- 239000000126 substance Substances 0.000 title 1
- 241001465754 Metazoa Species 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- 210000002966 serum Anatomy 0.000 abstract 2
- 150000003626 triacylglycerols Chemical class 0.000 abstract 2
- 241000283707 Capra Species 0.000 abstract 1
- 241000543381 Cliftonia monophylla Species 0.000 abstract 1
- 241000125945 Protoparvovirus Species 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 239000002955 immunomodulating agent Substances 0.000 abstract 1
- 229940121354 immunomodulator Drugs 0.000 abstract 1
- 230000002584 immunomodulator Effects 0.000 abstract 1
- 229960001438 immunostimulant agent Drugs 0.000 abstract 1
- 239000003022 immunostimulating agent Substances 0.000 abstract 1
- 230000003308 immunostimulating effect Effects 0.000 abstract 1
- 230000001506 immunosuppresive effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/598,744 US4572834A (en) | 1984-04-10 | 1984-04-10 | Biologic and method of preparing same |
| EP85104272A EP0158317B1 (de) | 1984-04-10 | 1985-04-09 | Verfahren zur Herstellung eines biologischen Stoffes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE72756T1 true ATE72756T1 (de) | 1992-03-15 |
Family
ID=24396745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT85104272T ATE72756T1 (de) | 1984-04-10 | 1985-04-09 | Verfahren zur herstellung eines biologischen stoffes. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4572834A (de) |
| EP (1) | EP0158317B1 (de) |
| JP (1) | JPH0720874B2 (de) |
| AT (1) | ATE72756T1 (de) |
| CA (1) | CA1264032A (de) |
| DE (1) | DE3585416D1 (de) |
| WO (1) | WO1985004586A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4883662A (en) * | 1984-04-10 | 1989-11-28 | Clinical Biotechnologies, Inc. | Method of increasing natural killer cell population of cancer patients |
| US4687665A (en) * | 1984-04-10 | 1987-08-18 | Clinical Reference Laboratory, Inc. | Biologic and method of preparing same |
| US4772552A (en) * | 1984-04-23 | 1988-09-20 | Dana-Farber Cancer Institute, Inc. | Monoclonal antibody which recognizes a 200-220 KD antigen on natural killer cells |
| US5643565A (en) * | 1985-09-20 | 1997-07-01 | Chiron Corporation | Human IL-2 as a vaccine adjuvant |
| EP0308724B1 (de) * | 1987-09-22 | 1992-05-20 | Clinical Biotechnologies, Inc. | Verwendung von einer immunstimulanten biologisten Substanz zur Herstellung eines Medikaments zur Behandlung des menschlichen Immunschwächevirus |
| ATE83931T1 (de) * | 1987-09-22 | 1993-01-15 | Clinical Biotechnologies Inc | Methode fuer die behandlung von viraler gehirnentzuendung. |
| US5219578A (en) * | 1991-02-25 | 1993-06-15 | Innovet, Inc. | Composition and method for immunostimulation in mammals |
| US6927068B2 (en) * | 2002-01-30 | 2005-08-09 | The United States Of America As Represented By The Secretary Of The Navy | Rapid and non-invasive method to evaluate immunization status of a patient |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1171299A (en) * | 1914-07-13 | 1916-02-08 | Robert A Archibald | Leucocytic extract and method of making the same. |
| US2136131A (en) * | 1937-03-09 | 1938-11-08 | Robert G Green | Distemper vaccine and method of preparing the same |
| US2271818A (en) * | 1939-02-06 | 1942-02-03 | Fromm Lab Inc | Distemper vaccine and method of preparing the same |
| US2271819A (en) * | 1939-02-06 | 1942-02-03 | Fromm Lab Inc | Distemper vaccine and method of preparing the same |
| US3002888A (en) * | 1958-06-11 | 1961-10-03 | American Home Prod | Lipid-mobilizing composition |
| US3002887A (en) * | 1958-06-11 | 1961-10-03 | American Home Prod | Method of purifying a dialyzable lipid mobilizer contained in blood |
| US3128230A (en) * | 1961-04-04 | 1964-04-07 | Sunbury Milk Products Co | Milk having antibodies therein and process for producing same |
| NL300960A (de) * | 1962-11-27 | |||
| US3577525A (en) * | 1964-07-01 | 1971-05-04 | Cornell Res Foundation Inc | Adenovirus vaccine against canine hepatitis |
| US3465077A (en) * | 1964-07-01 | 1969-09-02 | Cornell Res Foundation Inc | Protecting horses against infectious equine rhinopneumonitis with live bovine rhinotracheitis virus inoculation |
| US3376198A (en) * | 1965-07-21 | 1968-04-02 | Collins Products Inc | Method of producing antibodies in milk |
| US3991182A (en) * | 1971-10-19 | 1976-11-09 | The Regents Of The University Of California | Transfer factor |
| GB1443948A (en) * | 1972-10-20 | 1976-07-28 | Piktor Ltd | Production of immunological material |
| US3911108A (en) * | 1973-02-14 | 1975-10-07 | Diamond Shamrock Corp | Process of producing bovine milk products containing specific antibodies |
| US3892627A (en) * | 1973-06-04 | 1975-07-01 | Rohm & Haas | Feline panleukopenia vaccine |
| US4193991A (en) * | 1978-12-20 | 1980-03-18 | Cornell Research Foundation, Inc. | Canine parvovirus vaccine |
| US4193990A (en) * | 1979-02-16 | 1980-03-18 | Cornell Research Foundation, Inc. | Heterotypic canine parvovirus vaccine |
| US4444887A (en) * | 1979-12-10 | 1984-04-24 | Sloan-Kettering Institute | Process for making human antibody producing B-lymphocytes |
| HU182087B (en) * | 1980-01-15 | 1983-12-28 | Mta Kiserleti Orvostudomanyi K | Process for preparing an active substance for the selective inhibition of the multiplication of normal cells and of cells in myeloide leukemia |
| DE3009126A1 (de) * | 1980-03-10 | 1981-10-08 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | Verfahren zur gewinnung von funktionell und morphologisch intakten und lebensfaehigen leukozyten aus blut |
| US4303645A (en) * | 1980-04-18 | 1981-12-01 | Cornell Research Foundation, Inc. | Modified living canine parvovirus vaccine |
| US4448879A (en) * | 1981-03-26 | 1984-05-15 | Hooper Trading Company | High yield process for in vitro production of serum-free and mitogen-free interleukin-2 |
-
1984
- 1984-04-10 US US06/598,744 patent/US4572834A/en not_active Expired - Lifetime
-
1985
- 1985-04-09 JP JP60501788A patent/JPH0720874B2/ja not_active Expired - Fee Related
- 1985-04-09 DE DE8585104272T patent/DE3585416D1/de not_active Expired - Fee Related
- 1985-04-09 WO PCT/US1985/000597 patent/WO1985004586A1/en unknown
- 1985-04-09 EP EP85104272A patent/EP0158317B1/de not_active Expired - Lifetime
- 1985-04-09 AT AT85104272T patent/ATE72756T1/de not_active IP Right Cessation
- 1985-04-09 CA CA000478531A patent/CA1264032A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61502680A (ja) | 1986-11-20 |
| DE3585416D1 (de) | 1992-04-02 |
| US4572834A (en) | 1986-02-25 |
| EP0158317A3 (en) | 1988-04-20 |
| WO1985004586A1 (en) | 1985-10-24 |
| EP0158317A2 (de) | 1985-10-16 |
| CA1264032A (en) | 1989-12-27 |
| EP0158317B1 (de) | 1992-02-26 |
| JPH0720874B2 (ja) | 1995-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE58900776D1 (de) | Verfahren zur herstellung von apolipoproteinen aus blutplasma- oder serumfraktionen. | |
| DE69132098D1 (de) | Verfahren zur amplifikation von nukleinsäuren | |
| ATE156830T1 (de) | Verfahren zur reinigung von nukleinsäuren | |
| DE69224124D1 (de) | Verfahren zur Herstellung von Dihomo-Gamma-Linolensäure und das in dieser enthaltende Lipid | |
| AT387247B (de) | Kombiniertes verfahren zur thermischen und chemischen behandlung von lignocellulosehaltiger biomasse und zur gewinnung von furfural | |
| DE69126762D1 (de) | Biologisches Verfahren zur Herstellung von Alpha-Hydroxyamid und Alpha-Hydroxysäure | |
| ATE96174T1 (de) | Verfahren zur herstellung von avermectine-b und die verwendeten kulturen. | |
| ATE81339T1 (de) | Verfahren zur herstellung von zyklischen sulfaten. | |
| DE59005469D1 (de) | Verfahren zur herstellung von dmt-zwischenprodukt bestimmter reinheit sowie dessen weiterverarbeitung zu reinst-dmt und/oder mittel- oder hochreiner terephthalsäure. | |
| DE3680632D1 (de) | Verfahren zur herstellung von kohlenstoffasern und diese kohlenstoffasern. | |
| DE3683678D1 (de) | Verfahren zur herstellung von nuetzlichen hochmolekulargewichtssubstanzen durch kultur von vermehrungsfaehigen tierzellen und dazu geeignetes kultursystem. | |
| ATE72756T1 (de) | Verfahren zur herstellung eines biologischen stoffes. | |
| DE3776857D1 (de) | Aequoringen-varianten und verfahren zur herstellung von entsprechenden aequorinproteinen. | |
| ATE104338T1 (de) | Verbesserte zusammensetzung zur isolierung und anreicherung von nukleinsaeure und dadurch verbessertes verfahren. | |
| ATE49185T1 (de) | Verfahren zur herstellung von halogen-magnesium- alanat und dessen verwendung. | |
| DE58908727D1 (de) | Verfahren für eine sterile Handhabung von strömungsfähigen Fermenterproben sowie Vorrichtung zur Durchführung des Verfahrens. | |
| ATE80309T1 (de) | Verfahren zur herstellung eines konzentrates von alpha-1-antitrypsin von menschlicher plasmafraktion und seine verwendung als arzneimittel. | |
| DE3776173D1 (de) | Verfahren zur herstellung von saeureamiden. | |
| ATE8585T1 (de) | Verfahren zur herstellung von blutplasmafraktionen. | |
| DE69220078D1 (de) | Verfahren und zusammensetzung zur bestimmung der immunologischen aktivitaet von bioaktiven substanzen | |
| DE3888648D1 (de) | Verfahren zur Herstellung von HgiAI-Restriktionsendonuklease und -methylase. | |
| DE3577372D1 (de) | Verfahren zur herstellung von sonnenzellen aus amorphem silizium und das dadurch erzeugte produkt. | |
| ATA118987A (de) | Kominiertes verfahren zur termischen und chemischen behandlung von lignocellulosehaltiger biomasse und zur gewinnung von furfural | |
| ATE67782T1 (de) | Cholesterolreiche fraktion, verfahren dafuer und verwendung derselben zur zellkultur. | |
| Benarous et al. | Isolation and partial characterization of a human prothrombin variant: Prothrombin Barcelona |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |